-
サマリー
あらすじ・解説
Drs. Karl and Spencer discuss the topline results from Surmount 5 which put Zepbound (tirzepatide) against Wegovy (semaglutide) for weight loss. They also discuss some news around compounded GLP-1s.
Learn:
Weight loss and glycemic differences between tirzepatide and semaglutide
What the FDA is thinking for compounded GLP-1s
If you're not on Dr. Spencer's virtual clinic waitlist, click here